Herceptin boost to battle against breast cancer
Herceptin became available in Ireland last year to treat the early stages of an aggressive form of breast cancer called HER2 which affects a third of all breast cancer patients, or almost 420 Irish women each year.
Research published this week shows the drug eradicates tumours in over half — 55% — of women suffering from inflammatory HER2 when it is used before chemotherapy.



